| Transplantation of ACE2- Mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia Journal article
Leng,Zikuan, Zhu,Rongjia, Hou,Wei, Feng,Yingmei, Yang,Yanlei, Han,Qin, Shan,Guangliang, Meng,Fanyan, Du,Dongshu, Wang,Shihua, Fan,Junfen, Wang,Wenjing, Deng,Luchan, Shi,Hongbo, Li,Hongjun, Hu,Zhongjie, Zhang,Fengchun, Gao,Jinming, Liu,Hongjian, Li,Xiaoxia, Zhao,Yangyang, Yin,Kan, He,Xijing, Gao,Zhengchao, Wang,Yibin, Yang,Bo, Jin,Ronghua, Stambler,Ilia, Lim,Lee Wei, Su,Huanxing, Moskalev,Alexey, Cano,Antonio, Chakrabarti,Sasanka, Min,Kyung Jin, Ellison-Hughes,Georgina, Caruso,Calogero, Jin,Kunlin, Zhao,Robert Chunhua. Transplantation of ACE2- Mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia[J]. Aging and Disease, 2020, 11(2), 216-228.
Authors: Leng,Zikuan; Zhu,Rongjia; Hou,Wei; Feng,Yingmei; Yang,Yanlei; et al.
  Favorite | TC[WOS]:840 TC[Scopus]:951 IF:7.0/7.1 | Submit date：2021/03/01
Ace2 Negative Cell Transplantation Covid-19 Function Recovery Immunomodulation Mesenchymal Stem Cells |
